Sector | Chemicals | Compare with Sector peers |
Industry | Chemicals | Compare with Industry peers |
Website | http://www.rossari.com | |
Market Cap | 4,193.17 Cr. | |
Enterprise Value(EV) | 4,269.84 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 22.72 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 33.40 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 47.00 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 183.44 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 4.14 | Calculated using Price: 759.00 |
Dividend Yield | 0.07 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.52 Cr. | 55,245,966 Shares |
FaceValue | 2 | |
About Rossari Biotech Ltd. | ||
The company is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products. The company's business is organized in three main product categories - (i) home, personal care and performance chemicals; (ii) textile specialty chemicals; and (iii) animal health and nutrition products. |
1 Day |
|
+0.10% |
1 Week |
|
+3.40% |
1 Month |
|
+10.96% |
3 Month |
|
-2.43% |
6 Month |
|
-4.32% |
1 Year |
|
+11.89% |
2 Year |
|
-18.87% |
5 Year |
|
|
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 8.18 | 6.99 | 27.27 | 36.33 | 41.88 | 31.83 | 23.11 | 16.17 | 12.52 | |
Return on Capital Employed (%) | 10.7 | 10.3 | 26.4 | 40.37 | 54.4 | 37.93 | 28.81 | 24.37 | 18.48 | |
Return on Assets (%) | 3.11 | 3.04 | 13.49 | 20 | 20.38 | 16.17 | 13.69 | 9.48 | 7.18 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 47 | 50 | 65 | 94 | 124 | 287 | 409 | 805 | 915 | 978 | |
Non Curr. Liab. | 9 | 7 | 2 | 4 | 37 | 69 | 59 | 251 | 183 | 83 | |
Curr. Liab. | 58 | 52 | 57 | 68 | 122 | 169 | 177 | 360 | 474 | 469 | |
Minority Int. | |||||||||||
Equity & Liab. | 114 | 109 | 124 | 166 | 283 | 525 | 645 | 1,417 | 1,572 | 1,530 | |
Non Curr. Assets | 46 | 46 | 47 | 60 | 123 | 178 | 263 | 742 | 723 | 687 | |
Curr. Assets | 69 | 63 | 77 | 106 | 160 | 346 | 381 | 675 | 848 | 843 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 114 | 109 | 124 | 166 | 283 | 525 | 645 | 1,417 | 1,572 | 1,530 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 171 | 179 | 233 | 292 | 516 | 600 | 709 | 1,483 | 1,656 | 1,764 | |
Other Income | 0 | 0 | 1 | 1 | 1 | 4 | 9 | 19 | 14 | 10 | |
Total Income | 171 | 179 | 234 | 293 | 517 | 604 | 719 | 1,502 | 1,670 | 1,774 | |
Total Expenditure | -156 | -166 | -209 | -247 | -439 | -495 | -586 | -1,307 | -1,441 | -1,525 | |
PBIDT | 15 | 13 | 25 | 46 | 78 | 108 | 132 | 195 | 229 | 249 | |
Interest | -5 | -4 | -2 | -1 | -3 | -4 | -3 | -13 | -22 | -20 | |
Depreciation | -5 | -5 | -4 | -5 | -12 | -17 | -23 | -48 | -63 | -60 | |
Taxation | -1 | -1 | -3 | -11 | -18 | -23 | -27 | -39 | -37 | -44 | |
Exceptional Items | |||||||||||
PAT | 4 | 3 | 16 | 29 | 46 | 65 | 80 | 98 | 107 | 125 | |
Minority Interest | 0 | 0 | |||||||||
Share Associate | 0 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 4 | 3 | 16 | 29 | 46 | 65 | 80 | 98 | 107 | 126 | |
Adjusted EPS | 1 | 1 | 3 | 6 | 9 | 13 | 15 | 18 | 19 | 23 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 24 | 71 | 57 | 48 | 29 | 152 | |
Cash Fr. Inv. | -20 | -36 | -190 | -37 | -299 | -181 | |
Cash Fr. Finan. | -5 | -29 | 157 | -25 | 292 | 61 | |
Net Change | -2 | 6 | 23 | -14 | 22 | 32 | |
Cash & Cash Eqvt | 1 | 6 | 29 | 15 | 37 | 70 |
Wed, 24 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates Intimation of Earnings Conference Call for investors and analysts on Tuesday, April 30, 2024 at 04:00 P.M. IST |
Sat, 20 Apr 2024
Board Meeting Intimation ROSSARI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 29-Apr-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
Tue, 09 Apr 2024
Disclosure under SEBI Takeover Regulations Sunil chariᅡᅠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaᅡᅠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ᅡᅠ |
Thu, 25 Apr 2024 |
High Increase in 1 Month |
CCI Overbought Zone |
Close Above Last Month High |
Closing Near 100 SMA |
Close Crossing Last Month High |